Daily Judi: Friday, March 17, 2023
Every day we scan the headlines for the best items that engage the clinical trial ecosystem, workflow solutions, and more—all the latest news you need to know. Here are today's stories:
Advisers to the U.S. Food and Drug Administration voted in support of full approval of Paxlovid for treatment of mild to moderate COVID-19 in high-risk adults. (CNN)
Sanofi joins Novo Nordisk and Eli Lilly in reducing insulin prices in the United States. (Fierce Pharma)
Medtronic received approval in Europe for its Affera mapping and ablation system, which will be available in Europe in the first half of 2023. (MedTech Dive)
Our Culture
“Dossiers and redaction are built within the Judi platform, which helps significantly with adjudication management—and the client collaborates on the process.”
–Jess, Program Manager
About Judi
Judi speeds and improves the world's clinical trial workflows. Our cloud-based platform has 120,000 users across 171 countries. We eliminate the chaos so clinical teams can focus on the patient, rather than the process. We are a SOC 2 certified collaboration platform.
